Comorbid Pain, Depression, and Anxiety: Multifaceted Pathology Allows for Multifaceted Treatment

被引:47
作者
Nicolson, Stephen E. [2 ]
Caplan, Jason P. [1 ,3 ]
Williams, Deldre E. [4 ]
Stern, Theodore A. [5 ,6 ]
机构
[1] St Josephs Hosp, Dept Psychiat, Phoenix, AZ 85013 USA
[2] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Psychiat, Bronx, NY USA
[3] Creighton Univ, Sch Med, Omaha, NE USA
[4] Baylor Coll Med, Houston, TX 77030 USA
[5] Massachusetts Gen Hosp, Boston, MA 02114 USA
[6] Harvard Univ, Sch Med, Cambridge, MA 02138 USA
关键词
analgesics; anxiety; depression; geriatrics; pain; psychiatry; psychosomatic medicine; psychotherapy; selective serotonin reuptake inhibitors; NEUROPATHIC PAIN; PLACEBO-RESPONSE; DOUBLE-BLIND; PHARMACOLOGICAL MANAGEMENT; PROPHYLACTIC TREATMENT; SUICIDAL IDEATION; PHYSICAL SYMPTOMS; PERSISTENT PAIN; PRIMARY-CARE; DISORDERS;
D O I
10.3109/10673220903463226
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The care of patients who suffer from physical pain and a psychiatric illness is typically challenging because of the complex interplay of affective, behavioral, cognitive, and physical aspects of pain. Psychiatrists are often asked to evaluate patients with pain because of a concern for comorbid depression and anxiety, and fears of suicidality as a result of pain. This article reviews the pathophysiology of comorbid pain, anxiety, and depression, along with the treatment modalities (pharmacologic, psychotherapeutic, and "alternative") that may benefit all three conditions. (HARV REV PSYCHIATRY 2009;17:407-420.)
引用
收藏
页码:407 / 420
页数:14
相关论文
共 50 条
  • [21] The Cost of Comorbid Depression and Pain for Individuals Diagnosed With Generalized Anxiety Disorder
    Zhu, Baojin
    Zhao, Zhongyun
    Ye, Wenyu
    Marciniak, Martin D.
    Swindle, Ralph
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2009, 197 (02) : 136 - 139
  • [22] Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide
    Pini, S
    Amador, XF
    Dell'Osso, L
    Rossi, NB
    Cassano, P
    Savino, M
    Cassano, GB
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (01) : 15 - 21
  • [23] Comorbid depression and treatment of anxiety disorders, OCD, and PTSD: Diagnosis versus severity
    Breteler, J. Klein
    Ikani, N.
    Becker, E. S.
    Spijker, J.
    Hendriks, G.
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 295 : 1005 - 1011
  • [24] Psychosocial stress and anxiety in musculoskeletal pain patients with and without depression
    Poleshuck, Ellen L.
    Bair, Matthew J.
    Kroenke, Kurt
    Damush, Teresa M.
    Tu, Wanzhu
    Wu, Jingwei
    Krebs, Erin E.
    Giles, Donna E.
    GENERAL HOSPITAL PSYCHIATRY, 2009, 31 (02) : 116 - 122
  • [25] Treating comorbid depression and anxiety
    Kuzel, RJ
    JOURNAL OF FAMILY PRACTICE, 1996, 43 (06) : S45 - S53
  • [26] How environmental enrichment balances out neuroinflammation in chronic pain and comorbid depression and anxiety disorders
    Kimura, Louise F.
    Novaes, Leonardo S.
    Picolo, Gisele
    Munhoz, Carolina D.
    Cheung, Chi W.
    Camarini, Rosana
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (08) : 1640 - 1660
  • [27] The Association of Comorbid Depression and Anxiety Symptoms With Disability Onset in Older Adults
    Dong, Liming
    Freedman, Vicki A.
    Mendes de Leon, Carlos F.
    PSYCHOSOMATIC MEDICINE, 2020, 82 (02): : 158 - 164
  • [28] Anxiety, Depression, and Pain: Considerations in the Treatment of Patients with Uncontrolled Hypertension
    Hamam, Mohamed Serhan
    Kunjummen, Elizabeth
    Hussain, Md. Shahed
    Nasereldin, Mohamed
    Bennett, Stephanie
    Miller, Joseph
    CURRENT HYPERTENSION REPORTS, 2020, 22 (12)
  • [29] Anxiety, Depression, and Pain: Considerations in the Treatment of Patients with Uncontrolled Hypertension
    Mohamed Serhan Hamam
    Elizabeth Kunjummen
    Md. Shahed Hussain
    Mohamed Nasereldin
    Stephanie Bennett
    Joseph Miller
    Current Hypertension Reports, 2020, 22
  • [30] Treatment of Comorbid Anxiety and Depression with Escitalopram: Results of a Post-Marketing Surveillance Study
    Laux, G.
    Friede, M.
    Mueller, W. E.
    PHARMACOPSYCHIATRY, 2013, 46 (01) : 16 - 22